Patents for C07C 59 - Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups oh, o-metal, cho, keto, ether, groups, groups, or groups (14,643) |
---|
04/24/2007 | US7208623 Process for the manufacture of HMG-CoA reductase inhibitory mevalonic acid derivatives |
04/24/2007 | US7208615 Preferred salts are triple metal salts of calcium, magnesium or zinc and potassium; tasteless, odorless and highly water soluble; used in beverages, neutraceuticals and for treating obesity |
04/24/2007 | US7208524 5-amidino-2-hydroxybenzenesulfonamide derivatives, pharmaceutical compositions containing the same and intermediates for their preparation |
04/24/2007 | US7208118 Alkylating a basic mixture of oxoalkylated alcohols with a chlorocarboxylic acid, adding an acid to obtain ethercarboxylic acid, distillation under reduced pressure, removing the precipitated metal salts by filtration |
04/24/2007 | CA2307820C Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
04/24/2007 | CA2144312C Unsaturated aliphatic dicarboxylic acids |
04/19/2007 | US20070088084 Malic acid addition salts of terbinafine |
04/19/2007 | US20070088027 Carboxylic acid derivatives and pharmaceutical compositions comprising the same as an active ingredient |
04/18/2007 | EP1773750A1 Chemical compounds |
04/18/2007 | CN1950323A Crth2受体拮抗剂 Crth2 receptor antagonist |
04/18/2007 | CN1948262A Method of extracting amygdalic acid using strong alkali anion exchange resin |
04/18/2007 | CN1310881C New 3-aryl-2-hydroxypropionic acid derivative I |
04/17/2007 | US7205432 Process for the preparation of adamantane derivatives |
04/17/2007 | CA2269589C A solid-phase technology for the preparation of amides |
04/17/2007 | CA2203412C Bisarylcarbinol cinnamic acids as inhibitors of leukotriene biosynthesis |
04/12/2007 | WO2007039736A1 Novel compounds |
04/12/2007 | WO2007039125A2 An optically active thyroid receptor agonist and optically active key intermediates in its production |
04/12/2007 | US20070082954 Pharmaceutical compositions containing (+) cannabidioil and derivatives thereof and some such novel derivatives |
04/11/2007 | EP1572616B1 Selective reaction of hexafluoropropylene oxide with perfluoroacyl fluorides |
04/11/2007 | CN1944385A Method for separating and extracting abscisic acid from fermented liquid by ionic exchanging and reversed phase chromatography |
04/11/2007 | CN1944384A Coleus forskohlii extract main component and extracting method |
04/11/2007 | CN1944383A Alpha-alkoxy propionic acid compounds and their preparing method and medicine use |
04/11/2007 | CN1944382A Method for separating and purifying mandelic acid using wealk alkali anion exchange agent |
04/11/2007 | CN1944381A Method for preparing mandelic acid by macroporous adsorptive resin |
04/11/2007 | CN1944380A Method for extracting and purifying hydroxy-acetic acid by ester solvents |
04/11/2007 | CN1944379A New process for preparing hydroxy-acetic acid using hydroxy-acetic nitrile as raw material |
04/11/2007 | CN1944372A Process for preparing peach leaf mandelic acid extract |
04/11/2007 | CN1944371A Process for preparing DL-ortho-chloro mandelic acid |
04/11/2007 | CN1309700C Prepn process of 2-ary lactate, naprosyn and ibuprofen |
04/10/2007 | US7202213 Peroxisome Proliferator-Activated Receptor-alpha and Peroxisome Proliferator-Activated Receptor-gama activator and a Glucagon-Like Peptide-1; antidiabetic agents; insulin resistance; dyslipidemia; obesity; hypotensive agents |
04/05/2007 | WO2007038277A2 Resolution of alpha-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines |
04/05/2007 | WO2007022718B1 Alkyl aryl alkyl alcohols, their derivations and preparation process thereof |
04/05/2007 | CA2623355A1 Resolution of .alpha.-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines |
04/04/2007 | EP1227721B1 Novel substituted succinic acid metallo-beta-lactamase inhibitors and their use in treating bacterial infections |
04/04/2007 | CN1942424A New photoinitiators |
04/04/2007 | CN1939903A Mandelic acid derivatives and their use as throbin inhibitors |
04/04/2007 | CN1939902A Mandelic acid derivatives and their use as throbin inhibitors |
04/04/2007 | CN1308114C Flux of 1-methyl-4-isopropyl-bicyclic [2,2,2] octene-2,3-dicarboxylic acid and preparation method thereof |
04/03/2007 | CA2172519C Method of resolution of two enantiomers by crystallysation |
03/29/2007 | WO2007035760A1 Enhanced solubility of preformed calcium citrate by adding citric acid |
03/29/2007 | WO2007034924A1 METALLO-β-LACTAMASE INHIBITOR |
03/29/2007 | WO2007034719A1 Compound, method for producing same, positive resist composition and method for forming resist pattern |
03/29/2007 | WO2007033508A2 Organic compounds |
03/29/2007 | US20070073082 Resolution of alpha-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines |
03/29/2007 | CA2620675A1 Metallo-.beta.-lactamase inhibitors |
03/28/2007 | EP1767521A1 L-ornithine-citric acid salt crystal |
03/28/2007 | EP1765760A1 Phenyl derivatives comprising an acetylene group |
03/28/2007 | EP1765758A1 Highly soluble form of tricalcium citrate, and methods of its making and use |
03/28/2007 | CN1935769A Refining method capable of increasing citric-acid solubility |
03/28/2007 | CN1935131A Pharmaceutical use of 1 beta-hydroxy ilexolic acid for inhibiting hepatitis virus |
03/27/2007 | US7196119 compounds that agonize the membrane-associated estrogen receptor identified herein act as neuroprotectants to reduce neuronal cell death in response to ischemic stroke and inhibit reperfusion injury |
03/27/2007 | US7196081 Compounds with hydroxycarbonyl-halogenoalkyl side chains |
03/27/2007 | US7195752 Surfactant compounds and uses thereof |
03/27/2007 | CA2200084C Use of aromatic halides for treating mammalian cell proliferation |
03/22/2007 | WO2007033002A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
03/22/2007 | WO2007032409A1 Method for synthesis of keto acid or amino acid by hydration of acethylene compound |
03/22/2007 | US20070066844 Process for the preparation of lactic acid and glyceric acid |
03/22/2007 | CA2621949A1 Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders |
03/21/2007 | EP1763499A1 New photoinitiators |
03/21/2007 | EP1020422B1 (poly)alkylene glycol higher-alkyl ether derivative composition, and detergent, lubricant, and external-use skin preparation each containing the same |
03/21/2007 | EP0817643B1 Compounds and compositions for delivering active agents |
03/21/2007 | CN1934072A Therapeutic and carrier molecules |
03/21/2007 | CN1931827A 2- and 2,5-substituted phenylketo-enols |
03/21/2007 | CN1931821A Process of resolving optical isomer of 2-hydroxmethyl-3-phenylpropionic acid |
03/20/2007 | US7192982 Modulators of peroxisome proliferator activated receptors |
03/20/2007 | US7192970 Noncyclic 1,3-dicarbonyl compounds as dual PPAR agonists with potent antihyperglycemic and antihyperlipidemic activity |
03/20/2007 | US7192940 Ether compounds |
03/15/2007 | CA2621406A1 Pparactive compounds |
03/14/2007 | EP1762557A2 Aspirin-triggered lipid mediators |
03/14/2007 | EP1372667A4 Compositions for delivering bisphosphonates |
03/14/2007 | CN1930122A 1,3-diphenylprop-2-en-1-one derivative compounds, preparation method thereof and uses of same |
03/14/2007 | CN1930107A Particles of aluminum salt hydroxide containing organic acid anion, method for production thereof and use thereof |
03/14/2007 | CN1927808A Method of preparing 2,2-dimethyl-1-hydroxypropionic acid by chemical oxidization |
03/14/2007 | CN1927803A Method of preparing calcium propionate and calcium lactate with oyster shell as calcium source |
03/14/2007 | CN1927197A Medical use of 1beta-keto-5, 11(13)-diene eudesmane-12-acid for inhibiting hepatitis B virus |
03/14/2007 | CN1304372C Tri-substituted phenyl derivates useful as PDE IV inhibitors |
03/08/2007 | WO2007026875A1 PROCESS FOR PRODUCING OPTICALLY ACTIVE (S OR R)-α-HYDROXY ACID AND OPTICALLY ACTIVE (R OR S)-α-HYDROXY ACID ESTER |
03/08/2007 | WO2006134424A3 Method for the use of [11c] carbon monoxide in labeling synthesis of 11c-labelled acids by photo-induced free radical carbonylation |
03/07/2007 | EP1760067A2 Compounds with protected hydroxy groups |
03/07/2007 | EP1317408B1 Method for the purification of lactic acid on an industrial scale |
03/07/2007 | CN1926078A Process for recovering organic compounds from aqueous streams containing same |
03/07/2007 | CN1923787A Eudesmane type sesquiterpenes acid and application thereof |
03/07/2007 | CN1303052C Process for preparing Danshensu |
03/07/2007 | CN1303051C Process for preparing fluorocarboxylic acids |
03/06/2007 | US7186856 heating an ammonium salt of a carboxylic acid in the presence of a water immiscible organic amine to form an organic amine or ammonia and the acid; batch or contiuous processing; amine product can be reused |
03/06/2007 | CA2202228C Novel retinoids |
03/01/2007 | WO2007023173A1 A process for the conversion of furfuryl alcohol into levulinic acid or alkyl levulinate |
03/01/2007 | WO2007023129A2 Method for separating compound-forming chiral systems |
03/01/2007 | WO2007022718A1 Alkyl aryl alkyl alcohols, their derivations and preparation process thereof |
03/01/2007 | US20070049771 Contacting furfuryl alcohol and water or an alkyl alcohol with a porous heterogeneous strong acid ion-exchange resin that has pores with an average diameter of 1 to 1000 nm. |
03/01/2007 | US20070049639 Administering a combination of an omega-3 fatty acid and aspirin, to a patient suffering from inflammation, arthritis or cardiovascular diseases; reduced side effects; 13-hydroxy-DHA (13-hydroxy-DHA) |
02/28/2007 | EP1756062A1 Compounds and compositions as ppar modulators |
02/28/2007 | EP1756035A1 Radiation-curable coatings for metal substrates from multifunctional acrylate oligomers |
02/28/2007 | EP1756032A1 Crth2 receptor antagonists |
02/28/2007 | CN1922165A 3-(4-benzyloxyphenyl)propanoic acid derivative |
02/28/2007 | CN1922143A Alpha(trifluoromethyl-substituted aryloxy, arylamino, arylthio or arylmethyl)-trifluoromethyl-substituted phenylacetic acids and derivatives as antidiabetic agents |
02/28/2007 | CN1919823A Preparation method of lactate catalyst and application |
02/28/2007 | CN1301985C Method for extracting Vitamin C and gulonic acid from Vitamin C mother liquor |
02/28/2007 | CN1301969C New mandelic acid derivatives and their use as thrombin inhibitors |
02/27/2007 | US7183433 Ionic liquids and their use as solvents |